Abbvie Inc (NYSE:ABBV) shares, rose in value, with the stock price down by -0.15% to the previous day’s close as strong demand from buyers drove the stock to $185.34.
Actively observing the price movement in the recent trading, the stock is buoying the session at $185.62. The PE ratio was 79.03 over 12-month period. Referring to stock’s 52-week performance, its high was $218.66, and the low was $153.58. On the whole, ABBV has fluctuated by -5.01% over the past month.
With the market capitalization of Abbvie Inc currently standing at about $327.38 billion, investors are eagerly awaiting this quarter’s results, scheduled for in June. The company’s Forward Dividend Ratio is 6.38, with its dividend yield at 3.44%.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 59.88B, with a low estimate of 14.5B and a high estimate of 15.18B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 14.93B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ABBV’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 5.19, with the price of ABBV currently trading nearly -0.33% and -1.67% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 49.30, while the 7-day volatility ratio is showing 1.31% which for the 30-day chart, stands at 2.20%. Furthermore, Abbvie Inc (ABBV)’s beta value is 0.49, and its average true range (ATR) is 4.92.
A comparison of Abbvie Inc (ABBV) with its peers suggests the former has fared considerably weaker in the market. ABBV showed an intraday change of -0.15% in today’s session so far, and over the past year, it grew by 19.31%%.
Data on historical trading for Abbvie Inc (NYSE:ABBV) indicates that the trading volumes over the past 3 months, they’ve averaged 7.95 million. According to company’s latest data on outstanding shares, there are 1.77 billion shares outstanding.
Nearly 0.09% of Abbvie Inc’s shares belong to company insiders and institutional investors own 74.12% of the company’s shares. The stock has risen by 4.30% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ABBV stock heading into the next quarter.
